title: Diagnostic and therapeutic challenges. Progressive bilateral visual loss over the last seven years.
authors.affiliation: Associated Retinal Consultants, Royal Oak, Michigan, USA.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Drenser
authors.forename: George A
authors.initials: GA
authors.lastname: Williams
authors.forename: Arthur D
authors.initials: AD
authors.lastname: Fu
authors.forename: Cathy
authors.initials: C
authors.lastname: Egan
authors.forename: Philip G
authors.initials: PG
authors.lastname: Hykin
authors.forename: Pravin U
authors.initials: PU
authors.lastname: Dugel
authors.forename: P Kumar
authors.initials: PK
authors.lastname: Rao
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D004585:Electrooculography; D004596:Electroretinography; D005451:Fluorescein Angiography; D007839:Functional Laterality; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D012164:Retinal Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology*; D014786:Vision Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology*; D058609:Visual Field Tests
chemical_list: D000998:Antiviral Agents